Last updated: February 13, 2025
Sponsor: CardioFocus
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chest Pain
Dysrhythmia
Cardiac Disease
Treatment
pulsed field ablation
Clinical Study ID
NCT06828939
25-6073
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Recurrent symptomatic PAF with at least one documented episode
Failure or intolerance of at least one AAD
Age 18-75 years
Patient is indicated for an ablation procedure according to society guidelines orstudy site practice
Patient is willing and able to give informed consent/participate in baseline andfollow-up assessments for the duration of the study
Exclusion
Exclusion Criteria:
- overall good health as established by multiple criteria
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: pulsed field ablation
Phase:
Study Start date:
December 12, 2024
Estimated Completion Date:
May 31, 2026
Study Description
Connect with a study center
Na Homolce Hospital
Prague,
Czech RepublicActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.